Choi, J H

Selective involvement of reactive oxygen intermediates in platelet-activating factor-mediated activation of NF-kappaB. [electronic resource] - Inflammation Oct 2000 - 385-98 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

0360-3997

10.1023/a:1007068010645 doi


Acetylcysteine--pharmacology
Animals
Antioxidants--pharmacology
Azepines--pharmacology
Benzoquinones
DNA-Binding Proteins--metabolism
Disseminated Intravascular Coagulation--chemically induced
Female
Gene Expression Regulation--drug effects
Genistein--pharmacology
Hemorrhage--chemically induced
Hydrogen Peroxide--pharmacology
I-kappa B Proteins
Isoflavones--pharmacology
Kidney Medulla--blood supply
Lactams, Macrocyclic
Lethal Dose 50
Macrophages--drug effects
Mice
Mice, Inbred C57BL
NF-KappaB Inhibitor alpha
NF-kappa B--metabolism
Phosphorylation
Platelet Activating Factor--antagonists & inhibitors
Protein Processing, Post-Translational
Protein-Tyrosine Kinases--physiology
Pulmonary Edema--chemically induced
Pyrrolidines--pharmacology
Quinones--pharmacology
Reactive Oxygen Species--metabolism
Rifabutin--analogs & derivatives
Serine Proteinase Inhibitors--pharmacology
Signal Transduction--drug effects
Specific Pathogen-Free Organisms
Succinic Acid--pharmacology
Thiocarbamates--pharmacology
Tosylphenylalanyl Chloromethyl Ketone--pharmacology
Triazoles--pharmacology
Tumor Necrosis Factor-alpha--biosynthesis
Vitamin E--pharmacology